English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Shire
+
Community
Kacie Whaley
| Sep 1, 2017
Rare disease therapy company, Shire, making executive changes
+
Technology/Innovation
Marian Johns
| Aug 29, 2017
Shire, MircoHealth partner on app for hemophilia patients
+
Technology/Innovation
Nicholas Gueguen
| Aug 1, 2017
Immunodeficiency disease patients report higher quality of life with CUVITRU treatment
+
Community
Erianne Leatherman
| May 22, 2017
Shire outlines ADHD research at American Psychiatric Association meeting
Robert Hadley
| Apr 7, 2017
FDA accelerates review for drug that treats blood-clotting disease
+
Community
Gene Johnson
| Mar 5, 2017
Shire honors Rare Disease Day with launch of 'Rare Count'
Keri Carbaugh
| Feb 17, 2017
Shire provides latest data on Hunter's syndrome, Gaucher disease
+
Community
Keri Carbaugh
| Jan 8, 2017
Shire names Clark non-executive director
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
